Hui‐Wen Lo

9.8k total citations · 4 hit papers
113 papers, 7.7k citations indexed

About

Hui‐Wen Lo is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hui‐Wen Lo has authored 113 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Oncology, 53 papers in Molecular Biology and 41 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hui‐Wen Lo's work include Brain Metastases and Treatment (26 papers), Glioma Diagnosis and Treatment (25 papers) and HER2/EGFR in Cancer Research (21 papers). Hui‐Wen Lo is often cited by papers focused on Brain Metastases and Treatment (26 papers), Glioma Diagnosis and Treatment (25 papers) and HER2/EGFR in Cancer Research (21 papers). Hui‐Wen Lo collaborates with scholars based in United States, China and Germany. Hui‐Wen Lo's co-authors include Mien‐Chie Hung, Richard L. Carpenter, Francis Ali‐Osman, Hu Zhu, Weiya Xia, Xinyu Cao, Michael D. Chan, Yongkun Wei, Richard Carpenter and Mohamed Ali‐Seyed and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Cell.

In The Last Decade

Hui‐Wen Lo

110 papers receiving 7.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epidermal Growth Factor Receptor Cooperates with Signal Transducer and Activator of Transcription 3 to Induce Epithelial-Mesenchymal Transition in Cancer Cells via Up-regulation of TWIST Gene Expression

2007 526 citations Hui‐Wen Lo, Weiya Xia et al. Cancer Research profile →
Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI Inhibitors

2016 459 citations Tadas Rimkus, Shadi Qasem et al. profile →
STAT3 Target Genes Relevant to Human Cancers

2014 393 citations Richard L. Carpenter, Hui‐Wen Lo profile →
IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment

2022 173 citations Sara G. Manore, Daniel Doheny et al. profile →

Peers

Countries citing papers authored by Hui‐Wen Lo

Since Specialization

Citations

This map shows the geographic impact of Hui‐Wen Lo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui‐Wen Lo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui‐Wen Lo more than expected).

Fields of papers citing papers by Hui‐Wen Lo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui‐Wen Lo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui‐Wen Lo. The network helps show where Hui‐Wen Lo may publish in the future.

Co-authorship network of co-authors of Hui‐Wen Lo

This figure shows the co-authorship network connecting the top 25 collaborators of Hui‐Wen Lo. A scholar is included among the top collaborators of Hui‐Wen Lo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui‐Wen Lo. Hui‐Wen Lo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract A099: The IO-Atlas Project: A cross-cohort tumor immunophenotyping platform enhancing precision immuno-oncology 2025 ·Cancer Immunology Research ·Liqian Ma, Jacob Pfeil, Hui‐Wen Lo, Tolga Turan, Sarah Kongpachith, Xi Zhao, Josue Samayoa, Kyle Halliwill	1
2	Dual inhibition of the TrkA and JAK2 pathways using entrectinib and pacritinib suppresses the growth and metastasis of HER2-positive and triple-negative breast cancers 2024 ·Cancer Letters ·Angelina T. Regua, (unknown), (unknown), (unknown), (unknown), (unknown), Anneliese Gonzalez, (unknown), Jay‐Jiguang Zhu, (unknown), Hui‐Wen Lo	9
3	Bazedoxifene as a Potential Cancer Therapeutic Agent Targeting IL-6/GP130 Signaling 2024 ·Current Oncology ·(unknown), (unknown), Hui‐Wen Lo, Katherine H. R. Tkaczuk, Jiayuh Lin	6
4	Abstract 3769: Intracellular miR-1290 promotes breast cancer stemness in HER2-enriched and triple-negative breast cancer 2023 ·Cancer Research ·Grace Lai–Hung Wong, (unknown), Yoshua Esquenazi, Nitin Tandon, Angelina T. Regua, Hui‐Wen Lo	1
5	Breast cancer extracellular vesicles-derived miR-1290 activates astrocytes in the brain metastatic microenvironment via the FOXA2→CNTF axis to promote progression of brain metastases 2022 ·Cancer Letters ·Sherona Sirkisoon, Grace L. Wong, (unknown), Daniel Doheny, Dongqin Zhu, Angelina T. Regua, (unknown), Sara G. Manore, (unknown), Alexandra Thomas, Ravi Singh, Fei Xing, Guangxu Jin, Kounosuke Watabe, Hui‐Wen Lo	38
6	Trk receptor tyrosine kinases in metastasis and cancer therapy. 2019 ·PubMed ·Angelina T. Regua, Daniel Doheny, (unknown), Hui‐Wen Lo	14
7	Loss of XIST in Breast Cancer Activates MSN-c-Met and Reprograms Microglia via Exosomal miRNA to Promote Brain Metastasis 2018 ·Cancer Research ·Fei Xing, Yin Liu, Shih-Ying Wu, Kerui Wu, Sambad Sharma, Yin‐Yuan Mo, Jiamei Feng, Stephanie Sanders, Guangxu Jin, Ravi Singh, Pierre‐Alexandre Vidi, Abhishek Tyagi, Michael D. Chan, Jimmy Ruiz, Waldemar Debinski, Boris Pasche, Hui‐Wen Lo, Linda J. Metheny‐Barlow, Ralph B. D’Agostino, Kounosuke Watabe	259
8	Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44 2018 ·Cancer Research ·Tadas Rimkus, Richard L. Carpenter, Sherona Sirkisoon, Dongqin Zhu, Boris Pasche, Michael D. Chan, Glenn J. Lesser, Stephen B. Tatter, Kounosuke Watabe, Waldemar Debinski, Hui‐Wen Lo	32
9	The number of prior lines of systemic therapy as a prognostic factor for patients with brain metastases treated with stereotactic radiosurgery: Results of a large single institution retrospective analysis 2017 ·Clinical Neurology and Neurosurgery ·(unknown), E. McTyre, M.C. LeCompte, Christina K. Cramer, Ryan T. Hughes, Kounosuke Watabe, Hui‐Wen Lo, Stacey S. O’Neill, Michael T. Munley, Adrian W. Laxton, Stephen B. Tatter, Jimmy Ruiz, Michael D. Chan	5
10	Activation of the c-Met Pathway Mobilizes an Inflammatory Network in the Brain Microenvironment to Promote Brain Metastasis of Breast Cancer 2016 ·Cancer Research ·Fei Xing, Yin Liu, Sambad Sharma, Kerui Wu, Michael D. Chan, Hui‐Wen Lo, Richard L. Carpenter, Linda J. Metheny‐Barlow, Xiaobo Zhou, Shadi Qasem, Boris Pasche, Kounosuke Watabe	102
11	EGFR and HER2 signaling in breast cancer brain metastasis 2015 ·Frontiers in Bioscience-Elite ·Hui‐Wen Lo	57
12	HER2 Phosphorylates and Destabilizes Pro-Apoptotic PUMA, Leading to Antagonized Apoptosis in Cancer Cells 2013 ·PLoS ONE ·Richard L. Carpenter, Woody Han, Ivy Paw, Hui‐Wen Lo	15
13	Cyclooxygenase-2 Is a Novel Transcriptional Target of the Nuclear EGFR-STAT3 and EGFRvIII-STAT3 Signaling Axes 2010 ·Molecular Cancer Research ·Hui‐Wen Lo, Xinyu Cao, Hu Zhu, Francis Ali‐Osman	157
14	EGFR-Targeted Therapy in Malignant Glioma: Novel Aspects and Mechanisms of Drug Resistance 2010 ·Current Molecular Pharmacology ·Hui‐Wen Lo	113
15	A Novel Splice Variant of GLI1 That Promotes Glioblastoma Cell Migration and Invasion 2009 ·Cancer Research ·Hui‐Wen Lo, Hu Zhu, Xinyu Cao, Amy J. Aldrich, Francis Ali‐Osman	125
16	Nuclear‐cytoplasmic transport of EGFR involves receptor endocytosis, importin β1 and CRM1 2006 ·Journal of Cellular Biochemistry ·Hui‐Wen Lo, Mohamed Ali‐Seyed, Yadi Wu, Geoffrey Bartholomeusz, Sheng‐Chieh Hsu, Mien‐Chie Hung	190
17	Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival 2006 ·British Journal of Cancer ·Hui‐Wen Lo, Mien‐Chie Hung	260
18	Cancer‐Specific Gene Therapy 2005 ·Advances in genetics ·Hui‐Wen Lo, Chi‐Ping Day, Mien‐Chie Hung	56
19	Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2 2004 ·Cancer Cell ·Shao‐Chun Wang, Huang‐Chun Lien, Weiya Xia, (unknown), Hui‐Wen Lo, Zhiqin Wang, Mohamed Ali‐Seyed, Dung‐Fang Lee, Geoffrey Bartholomeusz, Fu Ou‐Yang, Dipak Kumar Giri, Mien‐Chie Hung	241
20	Structure of the human allelic glutathione S-transferase-π gene variant, hGSTP1C, cloned from a glioblastoma multiforme cell line 1998 ·Chemico-Biological Interactions* ·Hui‐Wen Lo, Francis Ali‐Osman	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact